Good evening :)
Place Order
Add to Watchlist

Aarey Drugs and Pharmaceuticals Ltd

AAREYDRUGS Share Price

70.942.00% (+1.39)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹199 cr, stock is ranked 2,480

High Risk

Stock is 3.56x as volatile as Nifty

AAREYDRUGS Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹199 cr, stock is ranked 2,480

High Risk

Stock is 3.56x as volatile as Nifty

AAREYDRUGS Performance & Key Metrics

AAREYDRUGS Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
49.511.50—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
36.776.430.79%

AAREYDRUGS Analyst Ratings & Forecast

—
Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

AAREYDRUGS Company Profile

Aarey Drugs & Pharmaceuticals is engaged in active pharmaceutical ingredient (API)/Bulk Drugs manufacturing.

AAREYDRUGS Similar Stocks (Peers)

Compare with peers Compare with peers 

AAREYDRUGS Similar Stocks (Peers)

Compare with peers Compare with peers 
Sun Pharmaceutical Industries Ltd
SUNPHARMA
PE Ratio
36.65
36.65
1Y Return
5.30%
5.30%
Buy Reco %
87.50
87.50
Cipla Ltd
CIPLA
PE Ratio
22.85
22.85
1Y Return
1.35%
1.35%
Buy Reco %
73.33
73.33
Torrent Pharmaceuticals Ltd
TORNTPHARM
PE Ratio
59.39
59.39
1Y Return
14.22%
14.22%
Buy Reco %
70.83
70.83
Dr Reddy's Laboratories Ltd
DRREDDY
PE Ratio
18.68
18.68
1Y Return
3.58%
3.58%
Buy Reco %
51.72
51.72
Mankind Pharma Ltd
MANKIND
PE Ratio
52.37
52.37
1Y Return
20.17%
20.17%
Buy Reco %
81.25
81.25
Compare with Peers

AAREYDRUGS Forecast

AAREYDRUGS Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

AAREYDRUGS

AAREYDRUGS

Income

Balance Sheet

Cash Flow

AAREYDRUGS Income Statement

AAREYDRUGS Income Statement

Industry refers to the sub-sector this company belongs to.
Lower than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 9.54%, vs industry avg of 10.1%

Constant Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share stayed at 0.12%

Lower than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of -6.99%, vs industry avg of 20.04%

Loading...

Financial YearFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue399.31352.53359.08306.78355.43495.43421.69402.58483.76483.76
Raw Materialssubtract386.12346.93347.45285.93335.96461.35418.98387.76471.69471.69
Power & Fuel Costsubtract0.040.040.040.010.000.040.030.03
Employee Costsubtract0.340.350.370.290.200.670.630.54
Selling & Administrative Expensessubtract2.623.043.824.943.886.894.527.83
Operating & Other expensessubtract-2.76-8.65-4.835.693.7312.42-12.93-4.99
Depreciation/Amortizationsubtract0.640.711.010.890.921.991.571.701.941.95
Interest & Other Itemssubtract4.331.922.231.792.442.042.874.384.024.02
Taxes & Other Itemssubtract2.512.012.441.451.783.482.240.662.082.08
EPS3.132.982.802.482.792.691.491.751.431.43
DPS0.000.000.100.000.000.000.000.000.000.00
Payout ratio0.000.000.040.000.000.000.000.000.000.00
See Costs

AAREYDRUGS Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
 

AAREYDRUGS Stock Peers

AAREYDRUGS Past Performance & Peer Comparison

AAREYDRUGS Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation-basic on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Aarey Drugs and Pharmaceuticals Ltd49.381.50—
Sun Pharmaceutical Industries Ltd36.655.530.96%
Cipla Ltd22.853.851.07%
Torrent Pharmaceuticals Ltd59.3914.950.18%

AAREYDRUGS Stock Price Comparison

Compare AAREYDRUGS with any stock or ETF
Compare AAREYDRUGS with any stock or ETF
AAREYDRUGS
Loading...

AAREYDRUGS Holdings

AAREYDRUGS Shareholdings

AAREYDRUGS Promoter Holdings Trend

AAREYDRUGS Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

AAREYDRUGS Institutional Holdings Trend

AAREYDRUGS Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

AAREYDRUGS Shareholding Pattern

AAREYDRUGS Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding44.80%0.00%0.00%2.34%52.86%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

AAREYDRUGS Shareholding History

AAREYDRUGS Shareholding History

Dec '23MarJunSepDec '24Mar3.83%3.40%3.40%2.75%2.34%2.34%

AAREYDRUGS Insider Trades & Bulk Stock Deals

AAREYDRUGS Insider Trades & Bulk Stock Deals

Loading...

smallcases containing AAREYDRUGS stock

smallcases containing AAREYDRUGS stock

Looks like this stock is not in any smallcase yet.

AAREYDRUGS Events

AAREYDRUGS Events

AAREYDRUGS Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

AAREYDRUGS has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

AAREYDRUGS Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

AAREYDRUGS has not given any dividends in last 5 years

AAREYDRUGS Upcoming Dividends

AAREYDRUGS Upcoming Dividends

No upcoming dividends are available

AAREYDRUGS Past Dividends

AAREYDRUGS Past Dividends

Cash Dividend

Ex DateEx DateDec 13, 2018

Interim
Interim | Div/Share: ₹0.10

Dividend/Share

₹0.10

Ex DateEx Date

Dec 13, 2018

AAREYDRUGS Stock News & Opinions

AAREYDRUGS Stock News & Opinions

Earnings
Aarey Drugs & Pharmaceuticals standalone net profit declines 78.14% in the March 2025 quarter

Net profit of Aarey Drugs & Pharmaceuticals declined 78.14% to Rs 0.47 crore in the quarter ended March 2025 as against Rs 2.15 crore during the previous quarter ended March 2024. Sales declined 48.61% to Rs 108.10 crore in the quarter ended March 2025 as against Rs 210.35 crore during the previous quarter ended March 2024. For the full year,net profit declined 14.10% to Rs 4.02 crore in the year ended March 2025 as against Rs 4.68 crore during the previous year ended March 2024. Sales rose 19.80% to Rs 473.94 crore in the year ended March 2025 as against Rs 395.62 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales108.10210.35 -49 473.94395.62 20 OPM %-4.49-0.69 -0.471.13 - PBDT0.213.29 -94 8.049.72 -17 PBT1.632.14 -24 6.105.34 14 NP0.472.15 -78 4.024.68 -14 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Aarey Drugs & Pharmaceuticals to table results

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 May 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Aarey Drugs & Pharmaceuticals standalone net profit declines 29.41% in the December 2024 quarter

Net profit of Aarey Drugs & Pharmaceuticals declined 29.41% to Rs 0.72 crore in the quarter ended December 2024 as against Rs 1.02 crore during the previous quarter ended December 2023. Sales rose 74.93% to Rs 133.79 crore in the quarter ended December 2024 as against Rs 76.48 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales133.7976.48 75 OPM %1.643.53 - PBDT2.302.52 -9 PBT1.401.46 -4 NP0.721.02 -29 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Aarey Drugs & Pharmaceuticals to declare Quarterly Results

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live

5 months agoCapital Market - Live
Corporate
Aarey Drugs & Pharmaceuticals schedules EGM

Aarey Drugs & Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 2 January 2025 .Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Aarey Drugs & Pharmaceuticals anounces board meeting date

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 4 December 2024Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Aarey Drugs & Pharmaceuticals to hold board meeting

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 November 2024Powered by Capital Market - Live

7 months agoCapital Market - Live
Earnings
Aarey Drugs & Pharmaceuticals standalone net profit rises 30.08% in the September 2024 quarter

Net profit of Aarey Drugs & Pharmaceuticals rose 30.08% to Rs 1.60 crore in the quarter ended September 2024 as against Rs 1.23 crore during the previous quarter ended September 2023. Sales rose 81.81% to Rs 105.14 crore in the quarter ended September 2024 as against Rs 57.83 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales105.1457.83 82 OPM %3.553.20 - PBDT3.262.28 43 PBT1.751.01 73 NP1.601.23 30 Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Aarey Drugs & Pharmaceuticals to hold board meeting

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live

8 months agoCapital Market - Live
Corporate
Aarey Drugs & Pharmaceuticals to conduct board meeting

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 1 October 2024.Powered by Capital Market - Live

9 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) today?

    The share price of AAREYDRUGS as on 9th July 2025 is ₹70.94. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) share?

    The past returns of Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) share are
    • Past 1 week: -1.05%
    • Past 1 month: 23.89%
    • Past 3 months: 47.70%
    • Past 6 months: 25.11%
    • Past 1 year: 46.24%
    • Past 3 years: 95.16%
    • Past 5 years: 63.64%

  3. What are the peers or stocks similar to Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS)?

    The peers or stocks similar to Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) include:

  4. What is the market cap of Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) is ₹199.02 Cr as of 9th July 2025.

  5. What is the 52 week high and low of Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) share?

    The 52-week high of Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) is ₹74.80 and the 52-week low is ₹31.35.

  6. What is the PE and PB ratio of Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) stock?

    The P/E (price-to-earnings) ratio of Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) is 49.38. The P/B (price-to-book) ratio is 1.50.

  7. Which sector does Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) belong to?

    Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  8. How to buy Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) shares?

    You can directly buy Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) shares on Tickertape. Simply sign up, connect your demat account and place your order.